warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing/Ewing-like Sarcomas
Brief Description  
To compare the progression-free survival (PFS) of eligible subjects treated with regorafenib or placebo according to modified RECIST version 1.1.
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Soft Tissue
Status  
OPEN
Start Date  
08/06/2014
IRB Number  
00009559
Principal Investigator  
Livingston, Michael Balfour
Contact Name  
Caroline Watt

For More Information, Contact  Caroline  , Watt
Phone:  980-442-2017 Fax:    
Email:  Caroline.Watt@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204
Close